early CAncer Diagnosis Cancer biomarkers
detection of DNA
plasmon resonance groups
novel surface plasmon resonance imaging
prognosis  of colorectal cancer
proposed detection approache
plasmon-enhanced fluorescence spectroscopy
inventor of surface plasmon microscopy
tumor autoantibodies cancer biomarkers
early diagnosis
limited availability of low cost detection platforms
ultrasensitive detection of biomolecular systems
plasmon-enhanced fluorescence sensing technologies
new minimal-invasive detection approaches
cost of platform
sensitivity of factor
project
low cost mass production
ULTRAsensitive PLAsmonic devices
disposable integrated chips
disposable chip
proposed results
readout platforms design
lack of test sensitivity
integrated microfluidic circuit
bimodal industrial prototype
compact plasmonic-based device
wide spread use of similar approaches
need
European value chain
specificity
complex sample chemical modifications
functionalized nanostructures
Automated fabrication processes suitable
microRNA
world
analysis time
development
key
choice
blood
improvement
cross-disciplinary competencies
body fluids
partners
todayâ€™s available techniques
barriers
manufacturing
reduction
reason
simple assays
therapeutic interventions
team
pathological process
minutes
aim